Business News Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials



The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *